Sweta Misra

Dr. Sweta Misra

orcid
Research Scientist

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Journal of Photochemistry and Photobiology A: Chemistry
Verified
Journal Article
Closed access
RVRoshni V
Roshni V
Sweta MisraSweta Misra
Sweta Misra
MSManas Kumar Santra
Manas Kumar Santra
DODivya Ottoor
Divya Ottoor

27 April 2011 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
Sweta MisraSweta Misra
Sweta Misra
MVMeenakshi Verma
Meenakshi Verma
SMSunil Kumar Mishra
Sunil Kumar Mishra
SSShishir Srivastava
Shishir Srivastava
VLVijai Lakshmi
Vijai Lakshmi
SMShailja Misra-Bhattacharya
Shailja Misra-Bhattacharya

1 April 2012 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KSKoneni V. Sashidhara
Koneni V. Sashidhara
SSSuriya P. Singh
Suriya P. Singh
Sweta MisraSweta Misra
Sweta Misra
JGJyoti Gupta
Jyoti Gupta
SMShailja Misra-Bhattacharya
Shailja Misra-Bhattacharya

27 December 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
RRRuchi Roy
Ruchi Roy
SSSunil Kumar Singh
Sunil Kumar Singh
Sweta MisraSweta Misra
Sweta Misra
Recent work has suggested involvement of the immune system in biological therapies specifically targeting tumor microenvironment. Substantial advancement in the treatment of malignant tumors utilizing immune cells, most importantly T cells that play a key role in cell-mediated immunity, have led to success in clinical trials. Therefore, this article focuses on the therapeutic approaches and developmental strategies to treat cancer. This review emphasizes the immunomodulatory response, the involvement of key tumor-infiltrating cells, the mechanistic aspects, and prognostic biomarkers. We also cover recent advancements in therapeutic strategies.

1 April 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Sweta MisraSweta Misra
Sweta Misra
LSLav Kumar Singh
Lav Kumar Singh
PRPriyanka
Priyanka
JGJyoti Gupta
Jyoti Gupta
SMShailja Misra-Bhattacharya
Shailja Misra-Bhattacharya
DKDiksha Katiyar
Diksha Katiyar

19 January 2017 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
Sweta MisraSweta Misra
Sweta Misra
JGJyoti Gupta
Jyoti Gupta
SMShailja Misra-Bhattacharya
Shailja Misra-Bhattacharya
Galactofuranose is an essential cell surface component present in bacteria, fungi and several nematodes such as Caenorhabditis spp., Brugia spp., Onchocerca spp. and Strongyloides spp. This sugar maintains the integrity of parasite surface and is essential for virulence. UDP-Galactopyranose mutase (bmugm) plays a key role in Galf biosynthesis by catalyzing conversion of UDP-Galactopyranose into UDP-galactofuranose and knockout studies of the gene in Leishmania major, Mycobacterium and Aspergillus fumigatus displayed attenuated virulence while RNA interference study in C. elegans exhibited detrimental effects. Presence of UGM in several prokaryotic and eukaryotic microbial pathogens and its absence in higher eukaryotes renders it an attractive drug target. In the present study, RNA interference studies have been carried out to validate bmugm as an antifilarial drug target. RNA interference studies using two different sequences of siRNAs targeting bmugm were carried out. The in vitro gene silencing of adult B. malayi parasites was undertaken to observe the effects on parasites. Infective larvae were also exposed to siRNAs and their in vivo development in jirds was observed. The in vitro gene silencing induced by siRNA1 and 2 individually as well as together knocked down the bmugm gene expression causing impaired viability of the exposed worms along with extremely reduced motility, abridged microfilarial release and adversely effected embryogenesis. The combinatorial in vitro gene silencing revealed marginally better results than both the siRNAs individually. Thus, infective larvae were treated with siRNA combination which showed downregulation of bmugm mRNA expression resulting into sluggish larval movements and/or death. The siRNA-treated actively motile larvae when inoculated intraperitoneally into jirds demonstrated highly reduced transformation of these larvae into adult worms with detrimental effects on embryogenesis. The effects of gene silencing were long-lasting as the adult worms developed from siRNA-treated larvae showed noticeable knockdown in the target gene expression. The validation studies undertaken here conclude that bmugm is essential for the proper development and survival of the parasite and support its candidature as an antifilarial drug target.